Icon

EVISTA (nda020815)- (60MG)

RALOXIFENE HYDROCHLORIDE LILLY
60MG
Yes No
2017-Apr-14 Expired
2014-Sep-13 None
None No
EVISTA® is an estrogen agonist/antagonist indicated for: • Treatment and prevention of osteoporosis in postmenopausal women. • Reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis. • Reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer.
8 0 6
Total Other Developers 3
Drugs with Suitability No
60MG ** ** - - 6
NDA Sales Available Total Generic Sales Available
Yes 6
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ****** ******* ***************, *** *********** * **** ***., *********, *** **** (**) *****, ****** ****** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ******* ****** *** ******* ***************, ***. *********** ** ***** *****, *********, *** **** (**) *****-****, ****** ****** (***) ***
****** ****** ****** ***** ******** *.*.*. *********** ****** ****** ********** **, ******, *****, ******* (***) ***
****** ****** ****** *** ****** *************** ******* *********** ****, ****** ****, ******, *********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.